Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Raúl Adrián Cruz"'
Autor:
Claudia García-Morales, Daniela Tapia-Trejo, Margarita Matías-Florentino, Verónica Sonia Quiroz-Morales, Vanessa Dávila-Conn, Ángeles Beristain-Barreda, Miroslava Cárdenas-Sandoval, Manuel Becerril-Rodríguez, Patricia Iracheta-Hernández, Israel Macías-González, Rebecca García-Mendiola, Alejandro Guzmán-Carmona, Eduardo Zarza-Sánchez, Raúl Adrián Cruz, Andrea González-Rodríguez, Gustavo Reyes-Terán, Santiago Ávila-Ríos
Publikováno v:
Pathogens, Vol 10, Iss 12, p 1587 (2021)
In response to increasing pretreatment drug resistance (PDR), Mexico changed its national antiretroviral treatment (ART) policy, recommending and procuring second-generation integrase strand-transfer inhibitor (INSTI)-based regimens as preferred firs
Externí odkaz:
https://doaj.org/article/f615ace142d24be98a31847b2642c1d6
Autor:
Edgar Pérez‐Barragán, Samantha Pérez‐Cavazos, Juan Carlos Rodríguez‐Aldama, Raúl Adrián Cruz‐Flores
Publikováno v:
HIV Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d250b5ddb54e43ebf278594694025aa3
https://doi.org/10.1111/hiv.13462
https://doi.org/10.1111/hiv.13462
Autor:
Edgar Pérez-Barragán, Juan Carlos Rodríguez-Aldama, Paulina Rodríguez-Badillo, Karyme Guadalupe Villegas-Moreno, Gabriel Ezequiel Galindo-Magaña, Berenice González-Flores, Andrea González-Rodríguez, Raul Adrián Cruz-Flores
Publikováno v:
HIV Research & Clinical Practice, Vol 25, Iss 1 (2024)
Background The global shift in healthcare during the COVID-19 pandemic led to challenges in the care of people living with HIV. Methods We conducted a retrospective study that aimed to delineate sociodemographic, clinical characteristics and outcomes
Externí odkaz:
https://doaj.org/article/8fb9b33b2db242908bd35e6f06c128e8
Autor:
Gulden Eser-Karlidag, Enrique Chacon-Cruz, Yasemin Cag, Jose Arturo Martinez-Orozco, Humberto Gudino-Solorio, Raul Adrian Cruz-Flores, Andrea Gonzalez-Rodriguez, Daniela Martinez-Nieves, Mario Gomez-Zepeda, Andrea Calderon-Suarez, Hülya Çaşkurlu, Antonio Cascio, Ricardo Fernandez, Greisha M. Gonzales, Pedro Palma, Corneliu Petru Popescu, Roman Stebel, Botond Lakatos, Eva Nagy, Massimiliano Lanzafame, Amani El-Kholy, Buse Tuncer, Iva Christova, Stefka Krumova, Alexandre Naime Barbosa, Juan Pablo Escalera-Antezana, Ruben Castillo-Quino, Carlos Eduardo Gonzales-Flores, Miriam Moreira-Flores, Marcelo Felipe Batallanos-Huarachi, Christian Gomez-Davila, Rusmir Baljic, Tarsila Vieceli, Olumuyiwa Elijah Ariyo, Mireia Cairo Llobell, Osasona Oluwadamilola Gideon, Augustus Osborne, Umran Elbahr, Philippe Bossi, Antonella Tammaro, Alfonso J. Rodriguez-Morales, Hakan Erdem
Publikováno v:
New Microbes and New Infections, Vol 53, Iss , Pp 101154- (2023)
Background: Mpox is a rare zoonotic disease caused by the Mpox virus. On May 21, 2022, WHO announced the emergence of confirmed Mpox cases in countries outside the endemic areas in Central and West Africa. Methods: This multicentre study was performe
Externí odkaz:
https://doaj.org/article/f4ac1226f7d64f45ae11088bcede4c55
Autor:
Carlos Leonardo, Magis-Rodríguez, Adriana, Villafuerte-García, Raúl Adrián, Cruz-Flores, Patricia, Uribe-Zúñiga
Publikováno v:
Salud publica de Mexico. 57
To estimate the prevalence of delayed- initiation (DI) of antiretroviral therapy (ART) for people with HIV attended at the Ministry of Health (SS, for its initials in Spanish) in Mexico, and to describe its behavior over time (2008-2013) and differen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e28ffe2d65ae48abd5ec914e82db84c9
https://pubmed.ncbi.nlm.nih.gov/26545128
https://pubmed.ncbi.nlm.nih.gov/26545128
Autor:
Raúl Adrián Cruz-Flores, Adriana Villafuerte-García, Patricia Uribe-Zúñiga, Carlos Magis-Rodriguez
Publikováno v:
Salud Pública de México. 57:127
Objetivo. Estimar la prevalencia de inicio tardío (IT) de terapia antirretroviral (TAR) de personas con VIH atendidas en la Secretaría de Salud (SS) en México y describir su comportamiento en el tiempo (2008-2013) así como las diferencias que pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e33a3ab454f6afb283828b43bfb23fd0
https://doi.org/10.21149/spm.v57s2.7600
https://doi.org/10.21149/spm.v57s2.7600
Autor:
Teresita de Jesús CL; Department of Gynecology and Care for Victims of Sexual Assault, Clínica Especializada Condesa Iztapalapa, Mexico City, Mexico., Edgar PB; Department of Infectious Diseases, Clínica Especializada Condesa Iztapalapa, Mexico City, Mexico., Carlos Ruben NC; Department of Gynecology and Care for Victims of Sexual Assault, Clínica Especializada Condesa Iztapalapa, Mexico City, Mexico., Marla TR; Department of Mental Health, Clínica Especializada Condesa Iztapalapa, Mexico City, Mexico., Juan Carlos RA; Department of Infectious Diseases, Clínica Especializada Condesa Iztapalapa, Mexico City, Mexico., Raúl Adrián CF; Department of Epidemiology, Clínica Especializada Condesa Iztapalapa, Mexico City, Mexico., Andrea GR; Medical Director, Clínica Especializada Condesa, Mexico City, Mexico.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jul 25; Vol. 11 (8), pp. ofae436. Date of Electronic Publication: 2024 Jul 25 (Print Publication: 2024).